FDA announcement on OTC access to Plan B One-Step
Diabetes is a known cardiovascular risk factor and patients who develop glucose intolerance have an elevated risk for developing diabetes
More information on glucocorticoids and TUEs is available here
Results vary depending on workout intensity, diet, consistency, and overall lifestyle habits
6.8% on placebo in STEP 1 Most common timing / during the first 8 to 20 weeks of dose escalation Discontinuation rate due to GI events / approximately 4.5% in key trials Mechanism / delayed gastric emptying plus direct brainstem GLP-1 receptor activation Red-flag sign / inability to keep fluids down for more than 24 hours Emergency sign / hematemesis (bloody vomit), severe epigastric pain, or signs of pancreatitis Dose modification / your prescriber may hold or reduce the dose rather than discontinue Dehydration risk / higher in patients also taking SGLT2 inhibitors or diuretics Why Wegovy Causes Vomiting Semaglutide 2.4 mg triggers vomiting through two overlapping pathways: slowed gastric motility and direct central nervous system signaling
The best results come from pairing the medicine with food, activity, sleep, and stress routines you can keep